 |
|
| Reflex Sympathetic Dystrophy (RSD and CRPS) Reflex Sympathetic Dystrophy (Complex Regional Pain Syndromes Type I) and Causalgia (Complex Regional Pain Syndromes Type II)(RSD and CRPS) |
| Reply |
|
|
Thread Tools | Display Modes |
|
|
02-10-2017, 12:28 AM
|
#1 | |||
|
||||
|
Grand Magnate
|
Brightcloud, this paper sums up what is known, what is not known and what the possible risk factors of self-medication are for LDN fairly well The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
It might help you to make an informed choice about LDN.
__________________
Knowledge is power. |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: |
|
02-10-2017, 01:28 AM
|
#2 | ||
|
|||
|
Magnate
|
Quote:
Appreciate reading about LDN; especially the risk factors of self-medication. I am on a fairly high dose of Oxycontin but have been gradually lowering my dosage. It would be a while before this might even be considered. It was interesting to read the effect LDN has with bowel issues and the effect of anti-inflammatory treatment. Gerry |
||
|
|
Reply With Quote
|
| "Thanks for this!" says: |
|
02-10-2017, 05:47 AM
|
#3 | ||
|
|||
|
Junior Member
|
kiwi33,
Thank you so much for posting the link to the LDN research article. It is one that I had not seen before and contains a lot of helpful information. It is also hopeful that researchers may eventually discover other glial cell modulators. Brightcloud |
||
|
|
Reply With Quote
|
| "Thanks for this!" says: |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Questions | Traumatic Brain Injury and Post Concussion Syndrome | |||
| MRI Questions | Multiple Sclerosis | |||
| New Member, questions, questions!! | Multiple Sclerosis | |||
| Questions Questions Questions | Trigeminal Neuralgia | |||
| Hi all - few questions | Peripheral Neuropathy | |||
Hybrid Mode
